https://bluehorizononco.com/research-item/oncolytic-virus-therapies/2024-10-14T21:51:42+00:00https://bluehorizononco.com/research-item/neoantigen-vaccines/2024-09-03T18:08:57+00:00https://bluehorizononco.com/research-item/tumor-infiltrating-lymphocytes/2024-09-03T18:13:15+00:00https://bluehorizononco.com/research-item/checkpoint-inhibitors-expansion/2024-09-03T17:46:31+00:00https://bluehorizononco.com/research-item/bispecific-antibodies/2024-09-03T17:38:41+00:00https://bluehorizononco.com/research-item/car-t-cell-therapy/2024-09-03T17:39:41+00:00https://bluehorizononco.com/portfolio-item/natural-killer-cell-therapies/2024-10-14T21:58:00+00:00https://bluehorizononco.com/portfolio-item/rna-based-therapies/2024-10-14T22:09:03+00:00